These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 17556410)

  • 1. Procalcitonin as marker of infection in patients with Goodpasture's syndrome is misleading.
    Morath C; Sis J; Haensch GM; Zeier M; Andrassy K; Schwenger V
    Nephrol Dial Transplant; 2007 Sep; 22(9):2701-4. PubMed ID: 17556410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case report of efficiency of double filtration plasmapheresis in treatment of Goodpasture's syndrome.
    Hajime N; Michiko A; Atsunori K; Tatsuo K; Yuko N; Naoki O; Katsuhiko S
    Ther Apher Dial; 2009 Aug; 13(4):373-7. PubMed ID: 19695077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical spectrum of acute glomerulonephritis and lung haemorrhage (Goodpasture's syndrome).
    Holdsworth S; Boyce N; Thomson NM; Atkins RC
    Q J Med; 1985 Apr; 55(216):75-86. PubMed ID: 4011844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum procalcitonin in systemic autoimmune diseases--where are we now?
    Buhaescu I; Yood RA; Izzedine H
    Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A giant cell arteritis revealing a Goodpasture's syndrome].
    Alix PM; Belloi A; Berthoux É; Dijoud F; Villar E; Pariset C
    Nephrol Ther; 2018 Apr; 14(2):105-108. PubMed ID: 29290619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasculitis in Goodpasture's syndrome.
    Wu MJ; Rajaram R; Shelp WD; Beirne GJ; Burkholder PM
    Arch Pathol Lab Med; 1980 Jun; 104(6):300-2. PubMed ID: 6892868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of procalcitonin and C-reactive protein in serum and erythrocyte sedimentation rate in active autoimmune diseases in children].
    Korczowski B; Kowalczyk JR; Bijak M; Rusin J
    Pol Merkur Lekarski; 2003 Aug; 15(86):155-7. PubMed ID: 14648981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.
    Rothenburger M; Markewitz A; Lenz T; Kaulbach HG; Marohl K; Kuhlmann WD; Weinhold C
    Clin Chem Lab Med; 1999 Mar; 37(3):275-9. PubMed ID: 10353472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal protein A immunoadsorption for Goodpasture's syndrome in four Chinese patients.
    Hu W; Liu Z; Ji D; Xie H; Gong D; Li L
    J Nephrol; 2006; 19(3):312-7. PubMed ID: 16874690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
    Sitter T; Schmidt M; Schneider S; Schiffl H
    J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics and outcomes of patients with Goodpasture's syndrome.
    Shah MK; Hugghins SY
    South Med J; 2002 Dec; 95(12):1411-8. PubMed ID: 12597309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Procalcitonin in pediatric emergency departments for the early diagnosis of invasive bacterial infections in febrile infants: results of a multicenter study and utility of a rapid qualitative test for this marker.
    Fernández Lopez A; Luaces Cubells C; García García JJ; Fernández Pou J;
    Pediatr Infect Dis J; 2003 Oct; 22(10):895-903. PubMed ID: 14551491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.
    Pihusch M; Pihusch R; Fraunberger P; Pihusch V; Andreesen R; Kolb HJ; Holler E
    Eur J Haematol; 2006 Feb; 76(2):93-101. PubMed ID: 16405429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Goodpasture's disease in the absence of circulating anti-glomerular basement membrane antibodies as detected by standard techniques.
    Salama AD; Dougan T; Levy JB; Cook HT; Morgan SH; Naudeer S; Maidment G; George AJ; Evans D; Lightstone L; Pusey CD
    Am J Kidney Dis; 2002 Jun; 39(6):1162-7. PubMed ID: 12046026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Assay for determination of the serum procalcitonin level: biochemical and clinical evaluation].
    Shimetani N; Ohba Y; Shimetani K; Mashiko T; Matsuyama N; Ohtani H; Morii M
    Rinsho Byori; 2001 Jan; 49(1):56-60. PubMed ID: 11215485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of race on hospitalization outcomes for goodpasture's syndrome in the United States: nationwide inpatient sample 2003-2014.
    Cheungpasitporn W; Thongprayoon C; Mao MA; Boonpheng B; Bathini T; Vallabhajosyula S; Medaura J; Chewcharat A; Kanduri SR; Kovvuru K; Salim SA; Kaewput W
    Hosp Pract (1995); 2021 Feb; 49(1):22-26. PubMed ID: 32981378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ophthalmic features of fourteen cases of Goodpasture's syndrome.
    Rowe PA; Mansfield DC; Dutton GN
    Nephron; 1994; 68(1):52-6. PubMed ID: 7527505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of serum procalcitonin concentration in the ICU following severe burn.
    Bargues L; Chancerelle Y; Catineau J; Jault P; Carsin H
    Burns; 2007 Nov; 33(7):860-4. PubMed ID: 17532575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin as a marker of micro-inflammation in hemodialysis.
    Conti G; Amore A; Chiesa M; Mancuso D; Cirina P; Mengozzi G; Santoro A; Coppo R
    J Nephrol; 2005; 18(3):282-8. PubMed ID: 16013016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein and procalcitonin as markers of mortality in hemodialysis patients: a 2-year prospective study.
    Chauveau P; Level C; Lasseur C; Bonarek H; Peuchant E; Montaudon D; Vendrely B; Combe C
    J Ren Nutr; 2003 Apr; 13(2):137-43. PubMed ID: 12671838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.